Federated Hermes Amends Amphastar Pharma Stake as of Dec 31, 2023
Ticker: AMPH · Form: SC 13G/A · Filed: 2024-01-17T00:00:00.000Z
Sentiment: neutral
Topics: institutional-ownership, amendment, pharmaceuticals
TL;DR
**Federated Hermes updated its Amphastar stake, watch for market reaction.**
AI Summary
Federated Hermes, Inc. filed an amended SC 13G/A on January 17, 2024, disclosing its ownership of Amphastar Pharmaceuticals, Inc. common stock as of December 31, 2023. This filing, an amendment number 3, indicates a change in their previously reported holdings. For investors, this matters because Federated Hermes is a significant institutional investor, and changes in their stake can signal their confidence (or lack thereof) in Amphastar's future prospects, potentially influencing other investors.
Why It Matters
This filing shows an updated position from a major institutional investor, Federated Hermes, which can influence market perception and potentially the stock price of Amphastar Pharmaceuticals.
Risk Assessment
Risk Level: low — This filing is a routine update from an institutional investor and does not inherently signal high risk, but rather provides transparency.
Analyst Insight
An investor should note this update from Federated Hermes and consider it as one data point among many when evaluating Amphastar Pharmaceuticals, potentially looking for the specific change in share count in the full filing to gauge the significance of the amendment.
Key Players & Entities
- Federated Hermes, Inc. (company) — the institutional investor filing the SC 13G/A
- Amphastar Pharmaceuticals, Inc. (company) — the subject company whose stock is being reported
- December 31, 2023 (date) — the date of the event requiring the filing
- January 17, 2024 (date) — the filing date of the SC 13G/A
FAQ
What type of SEC filing is this document?
This document is an SC 13G/A, which is an amendment to a Schedule 13G filing, as stated in the 'FORM TYPE: SC 13G/A' and 'SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 3*)' sections.
Who is the subject company whose shares are being reported?
The subject company is Amphastar Pharmaceuticals, Inc., as indicated by 'SUBJECT COMPANY: COMPANY CONFORMED NAME: Amphastar Pharmaceuticals, Inc.'.
Who is the entity that filed this SC 13G/A?
The entity that filed this SC 13G/A is Federated Hermes, Inc., as stated under 'FILED BY: COMPANY CONFORMED NAME: FEDERATED HERMES, INC.'.
What was the 'Date of Event Which Requires Filing of this Statement'?
The 'Date of Event Which Requires Filing of this Statement' was December 31, 2023, as explicitly stated in the filing.
What is the CUSIP number for Amphastar Pharmaceuticals, Inc. common stock?
The CUSIP number for Amphastar Pharmaceuticals, Inc. common stock is 03209R103, as listed under 'CUSIP Number'.
Filing Stats: 2,868 words · 11 min read · ~10 pages · Grade level 9.3 · Accepted 2024-01-17 14:36:19
Filing Documents
- amph1566-form.htm (SC 13G/A) — 106KB
- image_001.jpg (GRAPHIC) — 114KB
- image_002.jpg (GRAPHIC) — 116KB
- 0001623632-24-000024.txt ( ) — 424KB
Ownership
Item 4. Ownership Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1. A. Federated Hermes, Inc. (a) Amount beneficially owned: 3,272,761 (b) Percent of class: 6.83% (c) Number of shares to which the person has: (i)Sole power to vote or to direct the vote: 3,272,761 (ii)Shared power to vote or to direct the vote: 0 (iii)Sole power to dispose or to direct the disposition of: 3,272,761 (iv)Shared power to dispose or to direct the disposition of: 0 B. Voting Shares Irrevocable Trust (a) Amount beneficially owned: 3,272,761 (b) Percent of class: 6.83% (c) Number of shares to which the person has: (i)Sole power to vote or to direct the vote: 3,272,761 (ii)Shared power to vote or to direct the vote: 0 (iii)Sole power to dispose or to direct the disposition of: 3,272,761 (iv)Shared power to dispose or to direct the disposition of: 0 C. Thomas R. Donahue (a) Amount beneficially owned: 3,272,761 (b) Percent of class: 6.83% (c) Number of shares to which the person has: (i)Sole power to vote or to direct the vote: 0 (ii)Shared power to vote or to direct the vote: 3,272,761 (iii)Sole power to dispose or to direct the disposition of: 0 (iv)Shared power to dispose or to direct the disposition of: 3,272,761 D. Ann C. Donahue (a) Amount beneficially owned: 3,272,761 (b) Percent of class: 6.83% (c) Number of shares to which the person has: (i)Sole power to vote or to direct the vote: 0 (ii)Shared power to vote or to direct the vote: 3,272,761 (iii)Sole power to dispose or to direct the disposition of: 0 (iv)Shared power to dispose or to direct the disposition of: 3,272,761 E. J. Christopher Donahue (a) Amount beneficially owned: 3,272,761 (b) Percent of class: 6.83% (c) Number of shares to which the person has: (i)Sole power to vote or to direct the vote: 0 (ii)Shared power to vote or to direct the
Ownership of Five Percent or Less of a Class
Item 5. Ownership of Five Percent or Less of a Class If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following: Instruction: Dissolution of a group requires a response to this item.
Ownership of More than Five Percent on Behalf of Another Person. NOT APPLICABLE
Item 6. Ownership of More than Five Percent on Behalf of Another Person. NOT APPLICABLE Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company. See Exhibit “1” Attached
Identification and Classification of Members of the Group: NOT APPLICABLE
Item 8. Identification and Classification of Members of the Group: NOT APPLICABLE
Notice of Dissolution of Group: NOT APPLICABLE
Item 9. Notice of Dissolution of Group: NOT APPLICABLE
Certification
Item 10. Certification (a) The following certification shall be included if the statement is filed pursuant to §240.13d-1(b); By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having the purpose or effect. (b) The following certification shall be included if the statement is filed pursuant to §204.13d-1(c): By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect. SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. Date: January 17, 2024 By: /s/J. Christopher Donahue Name/Title: J. Christopher Donahue, as President of Federated Hermes, Inc. Date: January 17, 2024 By: /s/Thomas R. Donahue Name/Title Thomas R. Donahue individually and as Trustee of Voting Shares Irrevocable Trust Date: January 17, 2024 By: /s/Ann C. Donahue Name/Title: Ann C. Donahue individually and as Trustee of Voting Shares Irrevocable Trust Date: January 17, 2024 By: /s/J. Christopher Donahue Name/Title J. Christopher Donahue individually and as Trustee of Voting Shares Irrevocable Trust The original statement shall be signed by each person on whose behalf the statement is filed or his authorized representative. If the statement is signed on behalf of a
CLASSIFICATION OF REPORTING PERSONS
ITEM 3 CLASSIFICATION OF REPORTING PERSONS Identity and Classification of Each Reporting Person IDENTITY CLASSIFICATION UNDER ITEM 3 Federated Hermes Equity Funds (d) Investment company registered under Section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8) Federated Hermes Insurance Series (d) Investment company registered under Section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8) Federated Hermes MDT Series (d) Investment company registered under Section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8) Federated Equity Management Company of Pennsylvania (e) Investment Adviser registered under Section 203 of the Investment Advisers Act of 1940 Federated Global Investment Management Corp. (e) Investment Adviser registered under Section 203 of the Investment Advisers Act of 1940 Federated Investment Counseling (e) Investment Adviser registered under Section 203 of the Investment Advisers Act of 1940 Federated MDTA LLC (e) Investment Adviser registered under Section 203 of the Investment Advisers Act of 1940 Federated Hermes, Inc. (g) parent Holding Company or control person, in accordance with Section 240.13d-1(b)(ii)(G) FII Holdings, Inc. (g) parent Holding Company or control person, in accordance with Section 240.13d-1(b)(ii)(G) Voting Shares Irrevocable Trust (g) parent Holding Company or control person, in accordance with Section 240.13d-1(b)(ii)(G) Thomas R. Donahue (g) parent Holding Company or control person, in accordance with Section 240.13d-1(b)(ii)(G) Ann C. Donahue (g) parent Holding Company or control person, in accordance with Section 240.13d-1(b)(ii)(G) J. Christopher Donahue (g) parent Holding Company or control person, in accordance with Section 240.13d-1(b)(ii)(G) Federated Hermes, Inc. (the “Parent”) is filing this schedule 13G because it is the parent holding company of Federated Equity Management Company of Pennsylvania, Federated Global Investment Management